Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1. | Pharm Biol | 2024 | 38571483 | PubTator, text mining | PubMed |
| OCTN2- and ATB0,+-targeted nanoemulsions for improving ocular drug delivery. | J Nanobiotechnology | 2024 | 38532399 | PubTator, text mining | PubMed |
| Cryo-electron microscopy-based drug design. | Front Mol Biosci | 2024 | 38501110 | PubTator, text mining | PubMed |
| Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. | J Hepatol | 2024 | 38450598 | PubTator, text mining | PubMed |
| Unlocking apoptosis in triple negative breast cancer: Harnessing "glutamine trap" to amplify the efficacy of lapatinib-loaded mixed micelles. | Biomater Adv | 2024 | 38442461 | PubTator, text mining | PubMed |
| Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma. | Cancer Lett | 2024 | 38431035 | PubTator, text mining | PubMed |
| USP48 deubiquitination stabilizes SLC1A5 to inhibit retinal pigment epithelium cell inflammation, oxidative stress and ferroptosis in the progression of diabetic retinopathy. | J Bioenerg Biomembr | 2024 | 38427128 | PubTator, text mining | PubMed |
| Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2. | Biosci Rep | 2024 | 38415405 | PubTator, text mining | PubMed |
| The impact of wound-healing assay, phorbol myristate acetate (PMA) stimulation and siRNA-mediated FURIN gene silencing on endogenous retroviral ERVW-1 expression level in U87-MG astrocytoma cells. | Adv Med Sci | 2024 | 38403160 | PubTator, text mining | PubMed |
| Mitochondria in disease: changes in shapes and dynamics. | Trends Biochem Sci | 2024 | 38402097 | PubTator, text mining | PubMed |
| CircCPA4 induces ASCT2 expression to promote tumor property of non-small cell lung cancer cells in a miR-145-5p-dependent manner. | Thorac Cancer | 2024 | 38400818 | PubTator, text mining | PubMed |
| Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches. | Pharmaceutics | 2024 | 38399253 | PubTator, text mining | PubMed |
| GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma. | Indian J Pathol Microbiol | 2024 | 38394402 | PubTator, text mining | PubMed |
| tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5. | Carcinogenesis | 2024 | 38366384 | PubTator, text mining | PubMed |
| IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. | Cell Death Dis | 2024 | 38316760 | PubTator, text mining | PubMed |
| The expression of ferroptosis-related genes in osteoporosis based on GEO. | Eur Rev Med Pharmacol Sci | 2024 | 38305593 | PubTator, text mining | PubMed |
| Claudin-4 modulates autophagy via SLC1A5/LAT1 as a tolerance mechanism for genomic instability in ovarian cancer. | bioRxiv | 2024 | 38293054 | PubTator, text mining | PubMed |
| Cancer metabolism and carcinogenesis. | Exp Hematol Oncol | 2024 | 38287402 | PubTator, text mining | PubMed |
| Oxygen and Iron Availability Shapes Metabolic Adaptations of Cancer Cells. | World J Oncol | 2024 | 38274726 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia. | Cell Death Discov | 2024 | 38267416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=15